ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Morg.st.b.v 26

Morg.st.b.v 26 (GO79)

0.00
0.00
(0.00%)
마감 26 12월 1:30AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

GO79 뉴스

공식 뉴스 전용
0개의 기사가 발견되었습니다.
dukeb dukeb 5 분 전
LOL. Next you're going to tell me that the jambalaya I had at the Minnesota State Fair that included fried Twinkies in it wasn't true to the Louisiana original recipe.

Charleys Philly Steaks founder and CEO Charley Shin tasted his first Philly Cheesesteak back in 1985 while attendin
Value_Investor Value_Investor 8 분 전
The premarket-session (before 9:30 AM) high on 12/17/24 was $1.94 which is $0.24 higher than your selling price! However, after 9:30 AM in the regular trading session (between 4:00 PM and 9:30 AM) the high was only $1.30 !

Anyway, TNXP will easily bounce back to $1.94 again after
TNXP
nowwhat2 nowwhat2 8 분 전
Gong Show

https://investorshub.advfn.com/uimage/uploads/2024/12/25/sqmcsbtc_121212_25_15d_530pm_100K_GONG_SHOW.jpg



https://investorshub.advfn.com/uimage/uploads/2024/12/25/sru[ybtc_121212_25_45d_410pm_BUSTOUT_INEVITABLE.jpg
BTCUSD
tbonaces80 tbonaces80 8 분 전
We go hard this week. Too many Capital firms bought in. Load the boat $6-$10 easy
RAPT
Top Penny Top Penny 13 분 전
Go IBIO!
IBIO
onehundredmph onehundredmph 13 분 전
Lol. Liquidity is drying up fast. Don't play stupid. Tic tok
CRGP
Top Penny Top Penny 13 분 전
$300 PPS someday
IBIO
Top Penny Top Penny 13 분 전
Adding soon
IBIO
Top Penny Top Penny 14 분 전
IBIO will be my main holding going forward!
IBIO
Riley4 Riley4 14 분 전
It’s 100%. No drug with almost no adverse effects is declined. Now what happens behind the scenes 🤷‍♂️ but will be approved, no matter what khyber pass hero says
NWBO
delerious1 delerious1 15 분 전
And.....the second best thing about NBRI is that there are so many Fundamental drivers coming up that it will be hard for new retail traders to ignore
NBRI
Steady_T Steady_T 16 분 전
Missling has said no meetings with the FDA until the paper is published. Some here has suggested that there won't be an FDA filing until the draft guidance becomes final guidance.

That suggests to me that the FDA filing will be no earlier than Feb or Mar. (guess). Unless the NDA is g
AVXL
Tiger Money Tiger Money 16 분 전
If you want to make real money.  You hold
KULR
nathanial nathanial 20 분 전
One would think that the FDA is aware of the 5 successful patients in India and start moving the ball forward here in the USA. Enough of the sprint meetings and followup questions.
RDGL
skitahoe skitahoe 21 분 전
Never is a very long time. I've believed many products were certain of approval in my lifetime. In a couple cases the regulator did delay them, but all that I felt certain of were eventually approved. I've felt certain that DCVax-L would eventually be approved, I still believe the chance is great
NWBO
Jp_SHMP Jp_SHMP 21 분 전
We should see the whale and the crow 
It's getting hot 

Road to greatness 
IGPK
bar1080 bar1080 22 분 전
Closing 1200 Walgreens stores will cost a fortune in impairments. I worry too when I see terms like Adjusted earnings per share.
WBA
Riley4 Riley4 25 분 전
Take it back to the Khyber pass, lol, lol 😂
NWBO
kennyt 335 kennyt 335 25 분 전
Sorry NASDAQ2020 •EVA
ELTP
jaramill jaramill 26 분 전
TRUMP-EFFECT==$HHSE ready to EXPLODE to the upside. They are partnered with Trump Media ($DJT) on the "Trump-Book" AMERICAN MANIFESTO.

Thanks to all HHSE longs who stuck it out during the tough times. BIG rewards are finally coming, mainly due to the CEO's HARD WORK and TENACITY, navi
DJT HHSE MILLION
Whalatane Whalatane 27 분 전
Happy Holidays Dew , many thx to you and the other contributors here , for all your informed insights
Kwi
janice shell janice shell 27 분 전
Bin Tuberville along with Trump. He's so stupid he'll never notice he's in the nuthouse.
delerious1 delerious1 28 분 전
I know, eh?
NeutrinoKid NeutrinoKid 30 분 전
This just in: New market report mentioning RespireRx:

Global Circadian Rhythm Sleep Disorder Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
Publisher: Maia Research
Published Date: Dece
RSPI